KUALA LUMPUR, April 15 -- Crown Bioscience has appointed Jean-Pierre Wery, PhD as executive chairman of the board, effective immediately.
According to a statement by the drug discovery and development service company, Dr Wery will also serve as chief technology officer for JSR Life Sciences LLC.
In this new role, Dr Wery will lead the JSR Life Sciences companies’ collaborative efforts to identify strategic synergies and develop innovative technologies, platforms and tools for the drug and biomarker research communities.
This leadership change ensures enhanced collaboration between CrownBio and the JSR Life Sciences family of companies to expand their already significant life sciences footprint.
In the same statement, CrownBio also announced the appointment of Armin Spura, PhD to succeed Dr Wery as chief executive officer (CEO), effective April 1.
As CEO, Dr Spura will drive the global corporate strategy for CrownBio, further strengthening the company’s position at the forefront of preclinical research services across oncology, metabolic disease and inflammation.
-- BERNAMA
No comments:
Post a Comment